EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Studies on the etiology and therapy of sjogrens syndrome 1. erythro phagocytic activity of peripheral blood monocytes in patients with sjogrens syndrome



Studies on the etiology and therapy of sjogrens syndrome 1. erythro phagocytic activity of peripheral blood monocytes in patients with sjogrens syndrome



Okayama Igakkai Zasshi 94(1-2): 25-34



The erythrophagocytic activity of peripheral blood monocytes in patients with Sjogren's syndrome (SjS) was investigated by using 51Cr-labeled SRBC [sheep erythrocyte] sensitized with anti-SRBC antibody (IgG). The phagocytic activity of monocytes in patients with SjS alone was similar to that in healthy adults. The phagocytic activity of monocytes in patients with SjS associated with systemic lupus erythematosus or rheumatoid arthritis was lower than that in healthy adults. There was no significant correlation between phagocytic activity and several clinical parameters such as serum rheumatoid factor, erythrocyte sedimentation rate, serum complement level or the doses of prednisolone administered.

(PDF emailed within 1 workday: $29.90)

Accession: 006516412

Download citation: RISBibTeXText



Related references

Studies on the etiology and therapy of sjogrens syndrome 2. effects of steroid hormone on patients with sjogrens syndrome without associated diseases. Okayama Igakkai Zasshi 94(1-2): 35-44, 1982

Chemokine saliva levels in patients with primary Sjogrens syndrome, associated Sjogrens syndrome, pre-clinical Sjogrens syndrome and systemic autoimmune diseases. Rheumatology 50(7): 1288-1292, 2011

Clinical studies on patients with sjogrens syndrome 2. characteristics of patients with sjogrens syndrome and the effect of cortico steroid therapy. Okayama Igakkai Zasshi 94(1-2): 59-72, 1982

Clinical studies on patients with sjogrens syndrome 1. labial salivary gland biopsies and xerostomia in patients with sjogrens syndrome. Okayama Igakkai Zasshi 94(1-2): 51-58, 1982

Partial purification and characterization of sjogrens syndrome a and sjogrens syndrome b antigens in sjogrens syndrome. Clinical Research 26(1): 24A, 1978

Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus sjogrens syndrome and sjogrens syndrome alone. Clinical & Experimental Immunology 48(2): 339-347, 1982

Functional disability and end organ damage in patients with primary Sjogrens syndrome, SLE, and SLE and Sjogrens syndrome. Arthritis & Rheumatism 39(9 SUPPL ): S67, 1996

Sjogrens syndrome I Serologic reactions in patients with Sjogrens syndrome with and without rheumatoid arthritis. Arthritis & Rheumatism 3(4): 287-297, 1960

Characterization of sicca symptoms in patients with sjogrens syndrome and 6 cases lacking subjective sicca features subclinical sjogrens syndrome. Tokai Journal of Experimental & Clinical Medicine 6(3): 229-240, 1981

Peripheral blood dendritic cells in patients with Sjogrens syndrome. Journal of Investigative Dermatology 121(5): 1251, November, 2003

Keratoconjunctivitis sicca primary sjogrens syndrome and secondary sjogrens syndrome a clinical follow up over twelve years. Arthritis & Rheumatism 34(9 SUPPL): S82, 1991

A different immunological and cytokine profile of Sjogrens syndrome associated to HCV infection compared with primary Sjogrens syndrome. Arthritis & Rheumatism 42(9 SUPPL ): S140, Sept, 1999

Apoptotic cell death of peripheral blood lymphocytes in Sjogrens syndrome patients. Arthritis & Rheumatism 37(9 SUPPL ): S163, 1994

Disproportion of helper T cell subsets of peripheral blood in patients with primary Sjogrens syndrome. Arthritis & Rheumatism 42(9 SUPPL ): S139, Sept, 1999

Increased number of IL-6 and IL-10 secreting cells in peripheral blood from patients with primary Sjogrens syndrome. Arthritis & Rheumatism 41(9 SUPPL ): S298, Sept, 1998